| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.15 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |